Ginsenoside Rg5 enhances the radiosensitivity of lung adenocarcinoma via reducing HSP90-CDC37 interaction and promoting client protein degradation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginsenoside Rg5 enhances the radiosensitivity of lung adenocarcinoma via reducing HSP90-CDC37 interaction and promoting client protein degradation

Published:2023-11 Issue:11 Volume:13 Page:1296-1308
ISSN:2095-1779
Container-title:Journal of Pharmaceutical Analysis
language:en
Short-container-title:Journal of Pharmaceutical Analysis

Author:

Bai Hansong,Lyu Jiahua,Nie Xinyu,Kuang Hao,Liang Long,Jia Hongyuan,Zhou Shijie,Li Churong,Li Tao

Publisher

Elsevier BV

Subject

Analytical Chemistry,Electrochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Pharmacy

Reference60 articles.

1. The 2021 WHO classification of lung tumors: Impact of advances since 2015;Nicholson;J. Thorac. Oncol.,2022

2. Radiotherapy treatment for lung cancer: Current status and future directions;Vinod;Respirology,2020

3. Evidence-based estimates of the demand for radiotherapy;Delaney;Clin. Oncol. (R. Coll. Radiol.),2015

4. A population-based model of local control and survival benefit of radiotherapy for lung cancer;Shafiq;Clin. Oncol. (R. Coll. Radiol.),2016

5. Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments;Krause;Adv. Drug Deliv. Rev.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10

2. Graveoline attenuates D-GalN/LPS-induced acute liver injury via inhibition of JAK1/STAT3 signaling pathway;Biomedicine & Pharmacotherapy;2024-08

3. Integrating Chinese medicine into mainstream cancer therapies: a promising future;Frontiers in Oncology;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3